SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-003644
Filing Date
2018-05-01
Accepted
2018-05-01 16:06:09
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20180331x10q.htm 10-Q 1437979
2 EX-10.1 rigl-20180331ex1019a9e21.htm EX-10.1 263805
3 EX-31.1 rigl-20180331ex31193fc2b.htm EX-31.1 17780
4 EX-31.2 rigl-20180331ex31233eba7.htm EX-31.2 17800
5 EX-32.1 rigl-20180331ex3215f318d.htm EX-32.1 9454
  Complete submission text file 0001558370-18-003644.txt   4499573

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20180331.xml EX-101.INS 799739
7 EX-101.SCH rigl-20180331.xsd EX-101.SCH 28594
8 EX-101.CAL rigl-20180331_cal.xml EX-101.CAL 33934
9 EX-101.DEF rigl-20180331_def.xml EX-101.DEF 95183
10 EX-101.LAB rigl-20180331_lab.xml EX-101.LAB 258735
11 EX-101.PRE rigl-20180331_pre.xml EX-101.PRE 185925
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 18795521
SIC: 2834 Pharmaceutical Preparations